Bainan Biotech ApS: Financial statements 2021
CVR: 39904276
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
Bainan Biotech ApS (CVR 39904276) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK -3,709,804 and a net result of DKK -9,063,823 compared with DKK -509,902 the year before. Equity in the 2021 report amounted to DKK -9,414,885. The company had 9 employees in the financial year.
- Gross Profit
- DKK -3,709,804
- Profit/Loss
- DKK -9,063,823
- Equity
- DKK -9,414,885
- Total Assets
- DKK 5,645,819
- Employees
- 9
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | -3.7 mio. | -9.1 mio. | -9.4 mio. | 9 |
| 2020 | - | 2 mio. | -510 t. | -351 t. | 1 |
Official annual report
Find more companies like Bainan Biotech ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
As of November 10, 2021, Bolette Hartmann is registered as adm. dir. of Bainan Biotech ApS.
As of November 10, 2021, Ditte Riber has stepped down as adm. dir. of Bainan Biotech ApS.
Bainan Biotech ApS has published its annual report for 2020. Gross profit came to DKK 1,952,827, and the net result was DKK -509,902.
As of May 7, 2021, Ditte Riber is registered as adm. dir. of Bainan Biotech ApS.
As of May 7, 2021, Tue Alexander Emborg has stepped down as director of Bainan Biotech ApS.
About Bainan Biotech ApS
Bainan Biotech ApS was a Danish company of the type Anpartsselskab based in København N, founded in 2018. The company has been dissolved on 20 July 2026. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company has 2 employees (2024). In 2023, the company reported a gross profit of DKK -382,113 and a net result of DKK -2,671,977 compared with DKK -3,128,882 the year before. Equity in the 2023 report amounted to DKK -15,215,743.